8Epidemiology of gout: An update
Section snippets
Descriptive epidemiology
Gout is a crystal-deposition rheumatic disease. It is a more common inflammatory arthritis in men, characterised by formation of monosodium urate (MSU) crystals in the synovial fluid of joints and in other tissues. The crystals’ formation is caused by persistent urate levels in extracellular fluids (ascertained as serum uric acid levels) over the saturation threshold. Serum uric acid (sUA) is the endproduct of purine metabolism, in most cases, resulting from the inefficiency of renal urate
Geographical difference in occurrence/outcome of gout
Variation of the occurrence/outcome of gout due to geographical difference is described below. In addition, within similar geography, some variation of the disease was also presented.
What are the relevant risk factors for the occurrence of gout?
There were both non-modifiable and modifiable risk factors for hyperuricaemia and gout [92]. Non-modifiable risk factors included age and sex. In a Taiwanese population, where gout prevalence was exceptionally high, it was reported that 25% of the patients had their first gouty attack before the age of 30 years [87]. However, the disease was more commonly seen in an older population [93]. Gout primarily occurs in men but, in elderly patients, the ratio between men and women was less. In a
What are the time trends?
Trends in alcohol use, diet, obesity and MS in the general population might explain the increase in gout prevalence and incidence over time. In a population where gout was previously rare, the disease was more prevalent throughout Sub-Saharan Africa [89], [119]. Hyperuricaemia and gout were common among Maoris in New Zealand. Nevertheless, the prevalence of gout was reported to be on the increase, both in Maori and in Europeans, particularly in men. Compared to previous studies, in Maori men,
Difficulties in obtaining these informations: what are the weaknesses of the data reported above?
It was apparent that the classification criteria developed for the diagnosis of gout for population surveys, and epidemiological and clinical studies still required further investigation and validation. In addition, there were some variations in the sUA levels used to define hyperuricaemia in different studies reported on gout and/or hyperuricaemia. For example, the sUA levels ranging from 4.7 mg dl−1 to 6.6 mg dl−1 for women and from 5.7 mg dl−1 to 7.7 mg dl−1 for men were reported in the
Conclusion
Gout is a crystal-deposition rheumatic disease, more commonly seen in men and the older population. An update on the fundamental descriptive epidemiology of gout has considerably added to our knowledge and understanding of the disease. It is evident that there is an improvement on the clarity of the classification criteria for the diagnosis of gout, although further validation is still needed. Gout incidence and prevalence are influenced by the changes in diet, lifestyle and environmental
Acknowledgements
This work was supported by the Australian Commonwealth Department of Health and Ageing (to LM, ES). The funder had no role in the collection, analysis and/or interpretation of data or in the writing of the article.
References (125)
Gout
Medicine
(2006)- et al.
Hyperuricaemia and gout in western Samoans
Journal of Chronic Diseases
(1981) - et al.
The impact of gout on work absence and productivity
Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research
(2007 Jul–Aug) - et al.
The association between gout and nephrolithiasis in men: the health professionals’ follow-up study
Kidney International
(2003 Sep) - et al.
Rheumatic diseases in African blacks
Seminars in Arthritis and Rheumatism
(1994) Some unusual features of gouty arthritis in females
Seminars in Arthritis and Rheumatism
(1977 Feb)- et al.
Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout
Arthroscopy
(2009 Feb) - et al.
The online case-crossover study is a novel approach to study triggers for recurrent disease flares
Journal of Clinical Epidemiology
(2007 Jan) - et al.
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
Nature Genetics
(2008 Apr) - et al.
Synovial fluid analysis for diagnosis of intercritical gout
Annals of Internal Medicine
(1999 Nov 16)
Clinical features of gout in a cohort of Italian patients
Reumatismo
Principles of current management of primary gout
The American Journal of the Medical Sciences
Gout in a New England town. A prevalence study in Sudbury, Massachusetts
Annals of the Rheumatic Diseases
Serum uric acid levels and gout: what does this herald for the population?
Clinical and Experimental Rheumatology
Preliminary criteria for the classification of the acute arthritis of primary gout
Arthritis and Rheumatism
Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis
Journal of Clinical Rheumatology
The limited validity of the criteria of the American College of Rheumatology for classifying gout patients in primary care
Annals of the Rheumatic Diseases
EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
Annals of the Rheumatic Diseases
EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
Annals of the Rheumatic Diseases
Diagnosis of chronic gout: evaluating the american college of rheumatology proposal, European league against rheumatism recommendations, and clinical judgment
The Journal of Rheumatology
The gout diagnosis
Cleveland Clinic Journal of Medicine
The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study
Journal of Rheumatology
A prospective study of gout in New Zealand Maoris
Annals of the Rheumatic Diseases
Incidence and risk factors for gout in white men
The Journal of the American Medical Association
Epidemiology of gout: is the incidence rising?
Journal of Rheumatology
Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002–2003
Clinical and Experimental Rheumatology
Gout epidemiology: results from the UK general practice research database, 1990–1999
Annals of the Rheumatic Diseases
Gout and the risk of Parkinson’s disease: a cohort study
Arthritis & Rheumatism: Arthritis Care & Research
The pattern of rheumatic disorders seen amongst patients attending urban and rural clinics in west Africa
Clinical Rheumatology
Chronic inflammatory rheumatic diseases in black Zimbabweans
Annals of the Rheumatic Diseases
Risk factors for gout in Togolese patients
Joint Bone Spine: Revue du Rhumatisme
Prevalence of major rheumatic disorders in Jammu
JK Science
Diseases W-ICSWILoAfRCOPfCoR. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study
The Journal of the Association of Physicians of India
Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study
Journal of Rheumatology
Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community oriented programme for the control of rheumatic disease
Journal of Rheumatology
Prevalence of the major rheumatic disorders in the adult population of north Pakistan
British Journal of Rheumatology
Incidence and various risk factors for gout in the Georgian SSR
Terapevticheskiĭ Arkhiv
Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III
Rheumatology International
A population study of hyperuricaemia and gout in Japan–analysis of sex, age and occupational differences in thirty-four thousand people living in Nagano Prefecture
Ryumachi
Clinical features of 4000 gouty subjects in Japan
Advances in Experimental Medicine and Biology
Epidemiology of hyperuricemia and gout in Japan
Nippon Rinsho. Japanese Journal of Clinical Medicine
The epidemiology of gout and hyperuricemia in a rural population of Java
Journal of Rheumatology
Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China
Journal of Rheumatology
Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences
Journal of Rheumatology
The epidemiology of hyperuricaemia and gout in Taiwan aborigines
British Journal of Rheumatology
High prevalence of gout and related risk factors in Taiwan’s aborigines
Journal of Rheumatology
Rheumatic disease in an Australian aboriginal community in north Queensland, Australia. A WHO-ILAR COPCORD survey
Journal of Rheumatology
Gout is on the increase in New Zealand
Annals of the Rheumatic Diseases
Migration and gout: the Tokelau Island migrant study
British Medical Journal
Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands
Annals of the Rheumatic Diseases
Cited by (141)
Electrochemical sensing performance of nitrogen rich zero- and two-dimensional carbon nanomaterials modified electrodes towards purines catabolism
2022, Electrochimica ActaCitation Excerpt :For example, UA elevation into abnormally high levels is associated with gout [19], hypertension [20,21], cardiovascular [22,23] and renal diseases [24,25]. Gout is an inflammatory reaction primarily which occurs in the joints and forms UA crystals [19]. As the concentration of UA increases, UA crystal formation increases and this could enhance the vulnerability of gout.
Highly sensitive visual colorimetric sensor for xanthine oxidase detection by using MnO<inf>2</inf>-nanosheet-modified gold nanoparticles
2022, Spectrochimica Acta - Part A: Molecular and Biomolecular SpectroscopyKnowledge and attitudes of gout patients and their perspectives about diagnosis and management: A cross-sectional study in Saudi Arabia
2023, Immunity, Inflammation and Disease
- 1
Tel.: +61 2 9926 5065; fax: +61 2 9906 1859.
- 2
Tel.: +34 935 565609; fax: +34 935 565938.
- 3
Tel.: +34 946 006470; fax: +34 944 905985.